Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma
Journal of Clinical and Experimental Hematopathology · 26.12.2023 · 63 (4) · 262-265
DOI: 10.3960/jslrt.23043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical and Experimental Hematopathology, erschienen am 26.12.2023. Verfasst von Yasunobu Sekiguchi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Saitama Cancer Center, Saitama, Japan. Hauptthemen laut MEDLINE: Immunoconjugates, Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Saitama Cancer Center, Saitama, Japan.
- Department of Clinical Laboratory Medicine, Saitama Cancer Center, Saitama, Japan.
- Department of Inspection Engineering, Saitama Cancer Center, Saitama, Japan.
- Department of Pathology, Saitama Cancer Center, Saitama, Japan.
- Department of Hematology, Juntendo University Urayasu Hospital, Chiba, Japan.
Zitieren
APA
Sekiguchi, Y., Tsutsumi, H., Gomyo, A., Kudo, M., Iizaki, Y., Maseki, N., Kawamura, M., Kobayashi, K., Nishimura, Y., Kanda, H., Nitta, H., Noguchi, M., & Kobayashi, H. (2023). Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma. Journal of Clinical and Experimental Hematopathology, 63(4), 262-265. https://doi.org/10.3960/jslrt.23043
Vancouver
Sekiguchi Y, Tsutsumi H, Gomyo A, Kudo M, Iizaki Y, Maseki N, et al. Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma. Journal of Clinical and Experimental Hematopathology. 2023;63(4):262-265. doi:10.3960/jslrt.23043
BibTeX
@article{Sekiguchi2023,
author = {Sekiguchi, Yasunobu and Tsutsumi, Hiroki and Gomyo, Ayumi and Kudo, Masahisa and Iizaki, Yoshie and Maseki, Nobuo and Kawamura, Machiko and Kobayashi, Kazuhiko and Nishimura, Yu and Kanda, Hiroaki and Nitta, Hideaki and Noguchi, Masaaki and Kobayashi, Hirofumi},
title = {Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma},
journal = {Journal of Clinical and Experimental Hematopathology},
year = {2023},
volume = {63},
number = {4},
pages = {262--265},
doi = {10.3960/jslrt.23043}
}
EUVIMED